|
Number (%) of DPts on Targets of Metabolic Control according to ATP-III Panel and Steno Study |
||||||
| Baseline |
6 |
12 |
18 |
24 |
30 months |
|
|
|
||||||
| HbA1c < 7%: |
||||||
| - Group A |
25 (44) |
31 (55) |
32 (56) |
34 (60) |
28 (49) |
24 (42) |
| - Group B |
19 (33) |
22 (37) |
27 (46) |
31 (53) |
25 (43) |
27 (46) |
| HbA1c < 6.5%: |
||||||
| - Group A |
16 (28) |
14 (25) |
13 (23) |
21 (37) |
17 (30) |
21 (37) |
| - Group B |
15 (26) |
16 (27) |
18 (30) |
24 (41) |
22 (37) |
22 (37) |
| SBP < 130 mm Hg: |
||||||
| - Group A |
12 (21) |
21 (37) |
24 (42)* |
22 (39)* |
23 (41)* |
29 (51)* |
| - Group B |
14 (24) |
17 (29) |
28 (48)* |
28 (48)* |
24 (41)* |
25 (43)* |
| DBP < 80 mm Hg: |
||||||
| - Group A |
30 (53) |
44 (77) |
49 (86)* |
44 (77) |
45 (79)* |
47 (82)* |
| - Group B |
27 (46) |
44 (75) |
50 (85)* |
53 (90)* |
53 (90)* |
51 (86)* |
| Cholesterol < 200 mg/dl: |
||||||
| - Group A |
39 (68) |
50 (88)* |
51 (90)* |
48 (84)* |
54 (95)* |
53 (93)* |
| - Group B |
40 (68) |
45 (76)* |
48 (81)* |
52 (88)* |
55 (93)* |
56 (95)* |
| Triglycerides < 150 mg/dl: |
||||||
| - Group A |
44 (77) |
44 (77) |
48 (84) |
48 (84) |
47 (82) |
50 (88) |
| - Group B |
45 (76) |
40 (68) |
42 (71) |
43 (73) |
45 (76) |
48 (81) |
| HDL cholesterol (mg/dl) |
||||||
| Men > 40: |
||||||
| - Group A |
33 (77) |
33 (77) |
37 (86) |
39 (91) |
32 (74) |
30 (70) |
| - Group B |
28 (72) |
31 (80) |
31 (80) |
31 (80) |
30 (77) |
34 (87) |
| Women > 50: |
||||||
| - Group A |
9 (64) |
11 (79) |
10 (71) |
10 (71) |
12 (86) |
12 (86) |
| - Group B |
10 (50) |
12 (60) |
9 (45) |
8 (40) |
8 (40) |
11 (55) |
| LDL cholesterol < 100 mg/dl: |
||||||
| - Group A |
26 (46) |
41 (72)* |
38 (67)* |
44 (77)* |
50 (88)** |
48 (84)** |
| - Group B |
23 (39) |
33 (56)* |
37 (63)* |
46 (78)* |
51 (86)** |
46 (78)** |
| Apolipoprotein B < 100 mg/dl: |
||||||
| - Group A |
32 (56) |
45 (79)* |
48 (84)* |
48 (84)* |
52 (91)* |
53 (93)* |
| - Group B |
27 (46) |
42 (71)* |
42 (71)* |
51 (86)* |
50 (85)* |
50 (85)* |
| BMI < 25 Kg.m-2: |
||||||
| - Group A |
13 (23) |
12 (21) |
11 (19) |
13 (23) |
12 (21) |
13 (23) |
| - Group B |
5 (9)& |
5 (9)& |
5 (9)& |
9 (15)& |
7 (12)& |
7 (12)& |
| Waist Circumference |
||||||
| Men < 102 cm: |
||||||
| - Group A |
21 (49) |
18 (42) |
22 (51) |
23 (53) |
20 (47) |
20 (47) |
| - Group B |
17 (44) |
18 (46) |
16 (41)& |
19 (49) |
19 (49) |
19 (49) |
| Women < 88 cm: |
||||||
| - Group A |
3 (21) |
4 (29) |
5 (36) |
4 (29) |
4 (29) |
4 (29) |
| - Group B |
4 (20) |
5 (25) |
5 (25) |
6 (30) |
6 (30) |
6 (30) |
| ACR < 30 mg/g: |
||||||
| - Group A |
31 (54) |
32 (56) |
32 (56) |
34 (60) |
29 (51) |
29 (51) |
| - Group B |
26 (44) |
30 (51) |
27 (46) |
31 (53) |
25 (42) |
30 (51) |
| Current smokers: |
||||||
| - Group A |
11 (19) |
8 (14) |
8 (14) |
7 (12) |
7 (12) |
7 (12) |
| - Group B |
11 (19) |
8 (14) |
7 (12) |
7 (12) |
7 (12) |
7 (12) |
| Antiaggregated treatment: |
||||||
| - Group A |
50 (88) |
50 (88) |
50 (88) |
50 (88) |
50 (88) |
50 (88) |
| - Group B |
53 (90) |
53 (90) |
53 (90) |
53 (90) |
53 (90) |
53 (90) |
|
Group A, diabetic patients treated by endocrinology service. Group B, diabetic patients treated by coordinated team, Family Physician and endocrinologist, at primary care site. SBP, systolic blood pressure. DBP, diastolic blood pressure. BMI, body mass index. ACR, albumine-to-creatinine ratio. *p < 0.05, ** p < 0.01, denote differences in relation to baseline values. &p < 0.05, denote differences between Group A vs. Group B. | ||||||
Duran et al. BMC Endocrine Disorders 2008 8:9 doi:10.1186/1472-6823-8-9 |
||||||